Dynaccurate is a forward-thinking company that operates at the intersection of AI, Health Care, and Information Technology. Founded in 2020 and headquartered in Luxembourg, the company has developed an innovative platform that combines a modular Electronic Patient Record (EPR) and chemotherapy module. These modules are integrated with Artificial Intelligence for data annotation, dynamic terminology management for data harmonization, and blockchain consent management to enhance data sharing capabilities. Their technology is offered as a SAAS.
With its unique blend of cutting-edge technologies, Dynaccurate is well-positioned in the competitive healthcare-tech industry. The company last received a grant investment of €150.00K in January 2022 from LUXEM Ventures, illustrating investor confidence in its potential for growth and innovation. This recent funding marks a strategic stepping stone as they continue to leverage their core technologies to disrupt traditional healthcare data management systems.